EcoDrugPlus

Sucrase-Isomaltase

Ensembl ID : ENSCHOG00000012820
Gene Symbol: SI
1 Cross references
201 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSCHOG00000007186
Gene Symbol: SNCA
1 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSCHOG00000012481
Gene Symbol: TACR1
1 Cross references
271 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSCHOG00000009676
Gene Symbol: TACR3
1 Cross references
258 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSCHOG00000000987
Gene Symbol: THRB
1 Cross references
393 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSCHOG00000003285
Gene Symbol: TLR2
1 Cross references
249 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSCHOG00000012476
Gene Symbol: TLR4
1 Cross references
127 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSCHOG00000008472
Gene Symbol: TLR8
1 Cross references
199 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSCHOG00000010704
Gene Symbol: TGFBR1
1 Cross references
236 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSCHOG00000002664
Gene Symbol: TRPA1
1 Cross references
228 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSCHOG00000006943
Gene Symbol: TRPM8
1 Cross references
158 Possible Orthologues:

Transthyretin

Ensembl ID : ENSCHOG00000007339
Gene Symbol: TTR
1 Cross references
166 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).